Neuroscience

US FDA approves nasal spray for migraines

The US Food and Drug Administration has approved a fast-acting nasal spray from Pfizer designed to treat migraines, the US pharmaceutical giant said Friday.

Arthritis & Rheumatism

Virtual rehabilitation suite for arthritis patients

A new research project led by the University's Arthritis Research UK Biomechanics and Bioengineering Centre is using technology normally associated with Hollywood blockbusters to help tackle arthritis. Funded by Arthritis ...

Inflammatory disorders

Reducing risks for asthmatic mums-to-be

Pregnant women suffering from asthma could better manage the condition if additional integrated care involving education and monitoring was introduced in Australian hospitals, a new study has found.

Immunology

State of residency can increase children's risk of hay fever

If you think your child's stuffy nose is due to an autumn cold, you might want to consider allergies, especially if you live in the southern region of the United States. A study being presented this week at the Annual Scientific ...

Alzheimer's disease & dementia

Dementia a growing concern for China and the world

An ECU researcher is one of the lead authors of the first study analysing the increase in prevalence of Alzheimer's disease and other forms of dementia in China.

Diseases, Conditions, Syndromes

Don't let migraines ruin your holidays

(HealthDay)—The holidays can challenge the estimated 30 million migraine sufferers in the United States as they try to deal with crowds, travel delays, stress and other potential headache triggers.

page 20 from 24